Thanks tintinet.
Well worth a listen as Dr. Patrick talks for over 2 hours. Tim Ferriss allows the mp3 file to be downloaded. . Nate, she talks extensively about water only fasting, intermittent fasting and time restricted feeding starting at 13 minutes in.
She practices time restricted feeding which she counts only water as being allowed. She explains why. She is taking NR at a dose of 125 mg, if I heard correctly.
On the subject of NR/Sulforophane, I started taking them separated by about 6 hours. This is based on Turnbuckle's work related to Fission/Fusion, and the following study which I discovered about Sulforophane and Fusion.
Sulforophane: https://www.ncbi.nlm...les/PMC5126150/
"These results indicate that SFN treatment causes mitochondrial fusion independent of the canonical KEAP1-Nrf2-ARE pathway and led us to interrogate whether SFN directly affects components of the mitochondrial fission or fusion machinery.
In summary, we have identified a novel, cytoprotective function for the clinically-relevant compound SFN. In addition to activating the master anti-oxidant transcription factor Nrf2, SFN promotes mitochondrial and peroxisomal fusion, and this effect is independent of Nrf2. The mechanism underlying this phenomenon involves a reduction in the function of the GTPase Drp1, the primary mediator of mitochondrial and peroxisomal fission. A major consequence of SFN-mediated mitochondrial fusion is that cells become resistant to the toxic effects of the apoptosis inducer staurosporine. This additional cytoprotective action of SFN could be of particular clinical utility in the numerous neurodegenerative diseases for which age is the leading risk factor (e.g., Parkinson's Disease, Alzheimer's Disease, Age-related Macular Degeneration) as these maladies have been associated with apoptosis and reduced levels and/or dysregulation of Nrf2 [35], [36], [48]. Together, these data demonstrate that the cytoprotective properties of SFN extend beyond activation of the KEAP1-Nrf2-ARE system and warrant further studies given the current use of this agent in multiple clinical trials."
Edited by Heisok, 07 May 2017 - 09:33 PM.